Mar 24, 2020
Mar 23, 2020
What Goes Around Comes Around...
In 2011, I was part of a group of Camber Corporation
employees who went to Texas A&M University’s College Station campus in
response to a request by a former Camber client. This gentleman, a retired Marine Corps
Colonel, was working for the Texas A&M System, involved in managing
proposals to obtain large Government contracts.
At the time he contacted Camber, he was involved in responding to a
request for proposal (RFP) issued by the Department of Health and Human
Services’ Biomedical Advanced Research and Development Agency (BARDA). It was BARDA’s intent to have one or more Centers
for Innovation in Advanced Development and Manufacturing (CIADM) set up by the
successful bidder(s) responding to this RFP.
The centers were in direct response to a report published in August 2010
entitled “Report to the President on Reengineering the Influenza Vaccine
Production Enterprise to Meet the Challenges of Pandemic Influenza,”
These centers would involve the construction
of large and complex laboratories and production facilities capable of
developing and producing massive quantities of a vaccine in response to a
deadly influenza pandemic. (I seem to
recall that the goal was 120 million doses of vaccine within six months of the
adoption of a specific product). Can you see why I have been reflecting on this
recently?
We assembled in a conference room at an appointed time. In came the Colonel, neatly dressed in a dark
business suit, looking very professional.
“I don’t have much time,” he said.
“I’m trying to get thirty faculty members to respond to seventy
questions from the Government. They want
the answers by tomorrow night. Have you
ever herded cats?” He explained that the
reason he had called us to meet with him was that in his prior position, while
on active duty, our company, Camber Corporation, had provided exceptional
support services that helped him excel in his job performance. He then asked if
we could introduce ourselves and describe briefly how we might help him in his
proposal-developing effort. He was in a
hurry. The operative word was “briefly.
”
Unfortunately, some of my colleagues missed the
message. They rambled on about their
impressive resumes and broad professional experience. Some droned on for several minutes. Finally,
it was my turn to speak as the last in line. I took less than thirty seconds
for my response, ending with, “Colonel, I’d love the opportunity to support you
on this proposal.” He contacted us when
we returned to Huntsville. I was the
only one he wanted to hire to come back to College Station. I’m convinced to this day that my brevity and
consideration of his request was the main reason I was called back.
One of the skills I had mentioned in my brief oral portfolio
was planning and scheduling large, complex programs. When I had arrived back in College Station
and presented myself to our new client, he made my job clear. “I need for you to develop a detailed
schedule of the way we will execute this job from beginning to end. I have write-ups from the researchers and the
medical experts and the construction firms that are going to build the facilities. I need you to read all their narratives and
put it all together in a cohesive schedule.”
The proposal was due in about three weeks. I told him I’d give it my best shot.
Soon, I was poring over a pile of inputs from team
members. There were multiple large
construction firms that had joined the team.
Part of the job involved constructing a large office complex, a
state-of-the-art biological laboratory facility with the highest possible
biological safety level as defined by the Centers for Disease Control (CDC) and
NIH, and of course, the vaccine production facility, which would look like a
moderately-sized factory. Each of these
construction firms had taken a different approach toward their portion of the schedule.
Where one went to exquisite detail in describing their approach, another was
described in vague, summary detail.
Integrating them would be a challenge.
Regarding the laboratory facility, someone had laid out a
precise roadmap that included the sequence with which equipment had to be
installed and tested. I would need to
determine the lead time for acquiring much of the laboratory gear in order to
illustrate the ordering process in detail that would enable the orderly integration
of the lab. I began to construct the
overall framework of an integrated schedule, making dozens of phone calls to
clarify how the pieces would come together to create this massive pandemic
response complex.
Three weeks later, just in time to be included with the
massive proposal, my job was successfully completed. I presented the proposal team with a schedule
of nearly 1,500 tasks, all logically integrated, with data on who was assigned
to perform the task, where it would be performed, start and end dates,
accounting codes, and references to the Statement of Work sections that had
required the task. By employing the
database functions contained in the scheduling software, a user could reorient
the display to satisfy many different stakeholders.
The A&M Team was extremely pleased with the product I
contributed to their proposal. More
importantly, they went on to win one of the awards. Initial funding was around $176 Million, with
future growth potential of well over $1B.
Dr. Brett Giroir |
I worked on this proposal seven days a week while I was in
College Station. One of the proposal
team members with whom I worked (literally side-by-side, as our offices were in
adjacent spaces) was Dr, Brett Giroir, who was at that time Vice Chancellor for
the Texas A&M University System, and had come to the A&M System having
served as Director of DARPA's Defense Science Office from 2004 to 2008. Just a few days ago. I was watching the
Corona Virus Task Force daily briefing when I saw none other than Dr. Giroir
step to the podium. He is now a
four-star admiral in the U.S. Public Health Service Commissioned Corps, who
currently serves as the Assistant Secretary for Health under the Trump
administration. Among his collateral
duties, he concurrently serves as the director of the U.S. coronavirus
diagnostic testing. Talk about a small
world!
Subscribe to:
Posts (Atom)